L-carnitine supplementation in patients with HIV/AIDS and fatigue: a double-blind, placebo-controlled pilot study. - Wikidata - awgldk - TriplyDB

L-carnitine supplementation in patients with HIV/AIDS and fatigue: a double-blind, placebo-controlled pilot study.

L-carnitine supplementation in patients with HIV/AIDS and fatigue: a double-blind, placebo-controlled pilot study.

http://www.wikidata.org/entity/Q35121171

about

Effect of L-Carnitine in Patients With Liver Cirrhosis on Energy Metabolism Using Indirect Calorimetry: A Pilot Study.Plasma L-Carnitine and L-Lysine Concentrations in HIV-Infected Patients.

P2860

Q41627214-2DB7C619-7D98-4D4E-8FF6-B43A53B104D1 Q47547367-D39F07CF-A900-432C-9FDA-2A56609FFAE7

P2860

L-carnitine supplementation in patients with HIV/AIDS and fatigue: a double-blind, placebo-controlled pilot study.

http://www.wikidata.org/entity/Q35121171

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

name

L-carnitine supplementation in ...... lacebo-controlled pilot study.

@ast

L-carnitine supplementation in ...... lacebo-controlled pilot study.

@en

type

label

L-carnitine supplementation in ...... lacebo-controlled pilot study.

@ast

L-carnitine supplementation in ...... lacebo-controlled pilot study.

@en

prefLabel

L-carnitine supplementation in ...... lacebo-controlled pilot study.

@ast

L-carnitine supplementation in ...... lacebo-controlled pilot study.

@en

P1433

Q35121171-16862030-569F-4F38-A218-34E7B88CFCB5

P1476

Q35121171-FF948DC6-A4DA-4755-ABB3-43D4289775DD

P2093

Q35121171-1B661DF4-93AF-473A-A3F0-885459F54141

Q35121171-529893A4-4340-4474-B6BB-16C1CDEE20D3

Q35121171-6EF49AB5-52E0-4174-A45D-F5E463A2CEBD

Q35121171-9F46CE41-C366-4B5E-804F-B2FBD1A07D13

Q35121171-A656ABF4-6E65-484A-817E-0529478EA25D

Q35121171-E58761EC-F039-48A0-A371-77CE343B2F38

P2860

Q35121171-098462D1-EB22-465C-9187-3EFA4EF0A011

Q35121171-1142BAD4-8382-4FDB-8305-A0B72C444286

Q35121171-1B4AEEEA-10A9-4470-A03A-8F632A4074AD

Q35121171-2EA48FFE-0494-4992-8AA5-E1B336F01711

Q35121171-2F1864B9-71C0-472C-A54F-300DB649D6E8

Q35121171-39F86643-E34E-4CC3-A2A8-98FEB44FD04A

Q35121171-4DEABA6D-DF9C-4CFA-AEBB-66127A69C17A

Q35121171-54CAEA67-A333-425A-8F71-46FE77039404

Q35121171-5A6CEB9B-5C1F-46C7-BD93-EF69BFC3A356

Q35121171-5FBA0A7B-AB89-4386-8A32-A6EB610C1BC9

P304

Q35121171-EFD50590-BBB5-411F-8693-FE0939003691

P31

Q35121171-9B820327-5E58-4C21-969E-AF804AC71F7A

P356

Q35121171-52448808-4BBA-4CC4-864B-20328D730D8F

P407

Q35121171-23D6C6AD-2F51-47E5-95FF-1D34E414278D

P478

Q35121171-DD9278EF-D145-4E51-BA48-2C5674004FCA

P577

Q35121171-98263688-2722-4CAE-9272-FADF157B5405

P698

Q35121171-A18CB647-E77A-4DAC-9E75-ABF889013077

P921

Q35121171-09EF7A80-AF57-4435-865E-E675665431B3

Q35121171-A56F11D2-A50E-4E23-8C67-E29A791F5B05

P932

Q35121171-5C72FED5-7E1D-417F-A963-EE905D463BAA

P356

P1433

HIV/AIDS – Research and Palliative Care

P1476

L-carnitine supplementation in ...... lacebo-controlled pilot study.

@en

P2093

Ella Dvorkin

http://www.w3.org/2001/XMLSchema#string

Manuel Revuelta

http://www.w3.org/2001/XMLSchema#string

Nora Esteban-Cruciani

http://www.w3.org/2001/XMLSchema#string

Pauline Lesage

http://www.w3.org/2001/XMLSchema#string

Peter Homel

http://www.w3.org/2001/XMLSchema#string

Ricardo A Cruciani

http://www.w3.org/2001/XMLSchema#string

P2860

Bench-to-bedside review: severe lactic acidosis in HIV patients treated with nucleoside analogue reverse transcriptase inhibitors

“Mini-mental state”

L-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-α 2b plus ribavirin.

Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia

Clinical, laboratory, and neuroimaging characteristics of fatigue in HIV-infected individuals.

L-carnitine supplementation for the management of fatigue in patients with cancer: an eastern cooperative oncology group phase III, randomized, double-blind, placebo-controlled trial.

The use of levo-carnitine in children with renal disease: a review and a call for future studies.

Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients

Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy

l-carnitine and cancer cachexia: Clinical and experimental aspects.

P304

65-73

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/HIV.S66695

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25733927

http://www.w3.org/2001/XMLSchema#string

P921

P932

4340370

http://www.w3.org/2001/XMLSchema#string